Exploration of interactions between prognostic factors of stage I malignant melanoma

Melanoma Research

Volumn 6, Issue 4, 1996, Pages 319-324

  Helfenstein, U ^b   Schuler G ^a   Bopp, M ^b   Morf, S ^a   Schuler D ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Interaction; Malignant melanoma; Prognostic factors; Stage one melanoma; Subgroup analysis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0029831322     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199608000-00007     Document Type: Article

References (17)

1. Cascinelli N, Marubini E, Morabito A, et al. Prognostic factors for stage I melanoma of the skin: a review. Stat Med 1985; 4: 265-278.
2. Vollmer RT. Malignant melanoma, a multivariate analysis of prognostic factors. Pathol Annu 1989; 24: 383-407.
3. Garbe C, Büttner P, Bertz J, et al. Die Prognose des primären malignen Melanoms. In: Orfanos CE, Garbe C, eds. Das maligne Melanom der Haut. München: W Zuckschwerdt Verlag, 1990; 41-59.
4. Levy E, Silverman MK, Vossaert KA, et al. Late recurrence of malignant melanoma: a report of 5 cases, a review of the literature and a study of associated factors. Melanoma Res 1991; 1: 63-67.
5. Balch CM, Cascinelli N, Drzewiecki KT. A comparison of prognostic factors worldwide. In: Balch CM, Houghton AN, eds: Cutaneous Melanoma, 2nd ed. Philadelphia: JB Lippincott Company, 1992; 188-199.
6. Vossaert KA, Silverman MK, Kopf AW, et al. Influence of gender on survival of patients with stage I malignant melanoma. J Am Acad Dermatol 1992; 26: 429-440.
7. MacKie RM, Aitchison T, Sirel JM, et al. Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86 and their subsequent validation. Br J Cancer 1995; 71: 173-176.
8. Soong SJ. A computerized mathematical model and scoring system for predicting outcome in patients with localized melanoma. In: Balch CM, Houghton AN, eds. Cutaneous Melanoma, 2nd ed. Philadelphia: JB Lippincott Company, 1992; 200-212.
9. Cox DR. Regression models and life-tables (with discussion). J Roy Stat Soc, Ser B 1972; 34: 187-202.
10. Matthews DE, Farewell VT. Using and Understanding Medical Statistics. Basel: Karger, 1988: 155-166.
11. SAS Technical Report. P-217 SAS/STAT Software: The PHREG Procedure Version 6, Cary, NC: SAS Institute Inc, 1991.
12. Dixon WJ, ed. BMDP Statistical Software Manual. Berkeley: University of California Press, 1990: 769-806.
13. Mantel N. Why stepdown procedures in variable selection. Technometrics 1970; 12: 621-625.
14. Greenberg RS, Kleinbaum DG. Mathematical modeling strategies for the analysis of epidemiologic research. Ann Rev Publ Health 1985; 6: 223-245.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass 1958; 53: 457-481.
16. Sondergaard K, Schou G. Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. Virchows Arch [A] 1985; 406: 179-195.
17. Sondergaard K, Schou G. Therapeutic and clinicopathological factors in the survival of 1469 patients with primary cutaneous malignant melanoma in clinical stage I. Virchows Arch [A] 1985; 408: 249-258.